Inner Well-Being

Launched in 2015, BrainFutures works to accelerate access to science-based, brain health innovations that improve human outcomes. BrainFutures envisions a future where effective brain health practices are widely accessible to people of all ages, enabling advancements in learning, enhancement of cognitive performance, prevention of debilitating brain conditions and effective treatment of mental health and substance use conditions. Led by a cross-disciplinary advisory board of experts, BrainFutures fills a critical gap by providing rigorous analysis of practical advances in brain health.

The Office of Systems Catalyst (OSC) is a national, cross-sector collaborative of philanthropic leaders, and field experts working to accelerate the safe, ethical integration of innovative mental-health care into the U.S. healthcare system. OSC brings together philanthropic leaders, clinicians, researchers, and health-system experts to prepare the field for responsible adoption of emerging treatments.

Guided by three core pillars—Clinical Care and Operations, Workforce Development, and Data and Reimbursement—OSC focuses on the public-good infrastructure needed to support system readiness ahead of regulatory milestones. This work is done in collaboration with stakeholders across the ecosystem, including drug developers, providers, payers, national associations, and government partners, ensuring that philanthropic efforts complement—not duplicate—market-driven innovation.

By aligning strategy across sectors and coordinating catalytic projects, OSC helps translate scientific promise into safe, equitable, and sustainable access to high-quality care.

The International Arts + Mind Lab (IAM Lab) Center for Applied Neuroaesthetics is a multidisciplinary research-to-practice initiative at Johns Hopkins University that is accelerating the field of neuroarts through the study of neuroaesthetics.

IAM Lab is pioneering Impact Thinking, a translational research approach designed to solve intractable problems in health, well-being, and learning through the arts. IAM Lab brings together brain scientists and practitioners in the visual and performing arts, architecture and design, and creative arts therapies to foster collaboration and research. Our goal is to empower the global neuroaesthetics community to change the way we think today and enhance the way we live tomorrow.

https://www.artsandmindlab.org/

The Psychedelic Mental Health Access Alliance (PMHA Alliance) works to expand access to psychedelic-assisted therapy for people most impacted by trauma, poverty, and unmet mental health needs—especially people who have historically had the least access to emerging and breakthrough mental health treatments.

By focusing on how publicly funded psychedelic-assisted therapy (PAT) care is delivered in real-world settings, PMHA Alliance generates practical evidence to support policymakers, insurers, and state agencies in responsibly expanding access through public systems.

PMHA Alliance advances this work by serving as a bridge across education and collaboration. We are building an alliance to carry this work forward, bringing together legislators, advocacy organizations, community-based organizations, health equity leaders, clinicians, researchers, and people with lived experience to support publicly funded PAT care models that are grounded in community needs and built to last.

 

Psychedelic Science Funders Collaborative supports research on and clinical trials of physician-prescribed psychedelic medicines and patient access to these treatments. Begun in 2017, PSFC evaluates funding opportunities, advises scientists and organizations, and works to advance clinical approval of psychedelics. Existing psychiatric treatments fail to address the suffering of the hundreds of millions of people worldwide affected by conditions such as PTSD, depression, and addiction. Their work is intended to expand the treatment options available to those suffering from these chronic diseases.

Usona Institute
Founded in 2014, Usona Institute is a medical research organization dedicated to advancing the scientific understanding and therapeutic application of consciousness-expanding medicines. With a mission to address society's most challenging mental health conditions, Usona focuses on developing breakthrough treatments where existing solutions fall short.

A Global Center for Convening and Collaboration in Education
Usona Institute's purpose-built campus serves as a global center for research, collaboration, and learning. Positioned as a vital node in a network of emerging global centers, Usona brings together clinical researchers, integrative practitioners, and visiting scholars to advance psychedelic therapy and clinical care delivery models.

Through collaborations with leading organizations, Usona develops innovative curriculum and programs tailored to faculty, researchers, and practitioners preparing to scale future educational initiatives. These immersive and interactive learning experiences are designed to equip clinical, scientific, and academic leaders with the critical knowledge and skills required to foster innovation in preparation for the anticipated delivery of care, upon regulatory approval.

Participants benefit from expert faculty, experiential learning opportunities, and diverse guest speakers, gaining the expertise necessary to set the standard for best practices in psychedelic therapies and clinical research.

Learn more about Usona Institute.